INOVAIT provides Canada’s image-guided therapy (IGT) industry and academic institutions with targeted non-dilutive funding for commercialization-focused R&D projects involving the integration of artificial intelligence (AI) into IGT technologies. We will reimburse up to one-third of eligible supported project costs for projects selected through our application process.